Pharmacokinetic bioequivalence between (etonogestrel/ethinylestradiol 11.7/2.7 mg) NuvaRing® and Ornibel Premium® (etonogestrel/ethinylestradiol 8.25/2.6 mg), a novel polymer composition contraceptive vaginal ring [0.03%]
埃屈诺孕酮/炔雌醇阴道环(11.7/2.7毫克)的努瓦ering与奥妮倍尔Premium(埃屈诺孕酮/炔雌醇8.25/2.6毫克)的药代动力学生物等效性研究
María Ángeles Pérez de la Cruz,Carlos Diez,Sandra Urek et al.
María Ángeles Pérez de la Cruz et al.
Objective: This was a single-centre, randomised, single-ring insertion, 2-period, 2-sequence, crossover study designed to assess comparative bioavailability and thereby establish bioequivalence of two ethinylestradiol/eto...
From PCOS to PMOS: implications for contraceptive care and reproductive health [0.03%]
从PCOS到PMOS：对避孕护理和生殖健康的启示
Nefise Nazlı Yenigül,Berna Dilbaz
Nefise Nazlı Yenigül
Contraceptive dissatisfaction among women in Sweden: a cross-sectional survey [0.03%]
瑞典女性避孕不满状况的一项横断面调查研究
Moa Karberg,Tanja Tydén,Cerisa Obern et al.
Moa Karberg et al.
Purpose: To assess contraceptive dissatisfaction and examine its correlation with contraceptive methods and demographic factors in a Swedish population. Intention to switch methods was also assessed as a secondary measure...
POSITION PAPER ON Sexual and Reproductive Health and Rights Belgrade, 2026 [0.03%]
贝尔格莱德关于性与生殖健康和权利的立场文件 2026年
Teresa Bombas,Manuela Farris,Sharon T Cameron et al.
Teresa Bombas et al.
This position paper, issued by the European Society of Contraception and Reproductive Health (ESCRH) following its 18th Congress in Belgrade (2026), articulates a comprehensive, evidence-based and rights-centred stance on Sexual and Reprodu...
Two cases of pregnancy during the fourth year of 68 mg etonogestrel implant use [0.03%]
68mgetonogestrel植入第4年发生的2例妊娠病例报告
Allysa Warling,Lauren S Page,Hallie Nelson et al.
Allysa Warling et al.
Purpose: The United States Food and Drug Administration recently expanded approval of the 68 mg radiopaque etonogestrel (ENG) contraceptive implant (Nexplanon, Organon, Oss, The Netherlands) from three years to five years...
The missing half: a historical meta-narrative review of gendered responsibility in the history of contraception [0.03%]
缺失的一半：避孕历史中性别责任的历史元叙述评论
Heidi Stelling,Megan E L Brown,Amiee Trinder et al.
Heidi Stelling et al.
Introduction: The history of contraception is largely the history of women's contraception. Twentieth-century innovations and expanding sexual freedoms promised women greater reproductive control, yet male methods remaine...
Genital cosmetic surgery intention and its association with genital self-image and body exposure during sexual activity: a cross-sectional study [0.03%]
阴茎美容手术意愿及其与阴茎自我形象和性活动时裸露程度的关系：一项横断面研究
Hülya Özberk,Merlinda Aluş Tokat,Onur Yavuz et al.
Hülya Özberk et al.
Objectives: The aim of this study is to examine the relationship between genital self-image and body perception during sexual intercourse by determining women's intentions to undergo genital cosmetic surgery and their pre...
Mikaela Koch,Hasmik Adetyan,Serena Gill et al.
Mikaela Koch et al.
Objectives: FDA approval of the over-the-counter Opill® presents a significant opportunity to expand access to contraception in the United States. We aimed to assess the Opill's® availability, affordability, and accurac...
Current approaches to the diagnosis and management of retained products of conception and enhanced myometrial vascularity of the first trimester [0.03%]
现阶段有关妊娠早期胎盘残留物诊断和处理的策略及增强子宫肌层血管化的管理措施
Umberto Scovazzi,Anjeza Xholli,Elvira Primizia et al.
Umberto Scovazzi et al.
Introduction:Aim of this narrative review is to provide an update on diagnosis, management and outcome of RPOC and EMV diagnosed after first trimester pregnancy. Retained products of conception (RPOC) and enhanced myometrial vascularity (EM...